The project at a glance
Key Facts
Client
Euromechanics Medical GmbH
Acquiror
LAP GmbH
Target
Euromechanics Medical GmbH
Sellers
Roman Harmansa
Healthcare
Vertical
1–10M
Deal Size in EUR
Germany
Countries
'%20stroke='%238B7E68'/%3e%3cline%20id='Line%2018'%20x1='10.1035'%20y1='0.5'%20x2='10.1035'%20y2='8.6029'%20stroke='%238B7E68'/%3e%3crect%20id='Rectangle%201946'%20x='0.5'%20y='3.74561'%20width='39'%20height='35.237'%20rx='3.5'%20stroke='%238B7E68'/%3e%3cline%20id='Line%2019'%20x1='30.4219'%20y1='0.5'%20x2='30.4219'%20y2='8.6029'%20stroke='%238B7E68'/%3e%3c/g%3e%3c/svg%3e)
2017
Year
"I hadn't dealt with company valuation or sales before, so I needed a professional M&A advisory that would take the lead and let me focus on the day-to-day business. Mark Walther impressed me from our very first meeting with his honest, straightforward approach. With LAP, we found a strategic partner who continues the company, keeps the location, and secures all jobs — we're very happy with this succession solution.”
Roman Harmansa
Founder and former MD, Euromechanics Medical GmbH
Approach
Roman Harmansa wished to sell the company and set other priorities in this new phase of life. As there would be no internal succession despite four children, a strategic investor was preferred to guarantee a good home for his company.
Challenges
As the market segment was very narrow with only five competitors world-wide and no obvious buyer, Walther Transaction managed a broad bidding process. WT qualified 130 potential investors and received six offers of purchase. In a challenging final phase, LAP was identified as the best fit.
Results
Walther Transaction found a good home for Euromechanics in LAP, a company and strategic investor roughly ten times larger and with a high strategic fit. LAP offered a fair valuation, 100% takeover with a decent earn-out component and a secure transaction structure.
